Shigeaki Suzuki   Akiyuki Uzawa   Hiroyuki Murai   
Expert review of clinical immunology 18(12) 1207-1215 2022年12月
INTRODUCTION: The management of myasthenia gravis (MG) has been improved due to immunotherapy advances, but 20% of individuals with MG are refractory to the conventional therapy, and the need for novel biological drugs remains. AREA COVERED: The J...